Context Therapeutics Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
CNTX on Nasdaq
Location
2001 Market Street, Suite 3915 Unit #15, Philadelphia, PA

Insiders trading volume in the past year

Context Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Martin A. Lehr Chief Executive Officer, Director $769K +$70.1K +10% Jun 9, 2025
Evan G. Dick Former Section 16 officer $69.8K Feb 15, 2022
Alex Levit Chief Legal Officer, Corp. Sec $58K +$11.5K +24.8% Jun 6, 2025
Jennifer Lynn Minai-Azary Chief Financial Officer $51K +$25.5K +100% Jun 6, 2025
Tarek Sahmoud Chief Medical Officer $8.42K Aug 16, 2022
William F. Rencher Former Section 16 officer $1.4K Feb 15, 2022
Richard J. Berman Director Jun 13, 2024
Luke Walker Director Jun 12, 2025
Philip W. Kantoff Director Jun 12, 2025
Jennifer Evans Stacey Director Jun 12, 2025
Linda West Director Jun 12, 2025
Karen Deborah Chagin Chief Medical Officer Jun 9, 2025
Andy Pasternak Director Jun 12, 2025
Ullmann Claudio Dansky Chief Medical Officer Feb 13, 2025
Karen L. Smith Director Jun 12, 2025

Recent Insider Transactions by Companies or Individuals for Context Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.